FDA Approves Taiho's LYTGOBI® (futibatinib) Tablets for

FDA Approves Taiho's LYTGOBI® (futibatinib) Tablets for Previously Treated, Unresectable, Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma

FDA Approves Taiho's LYTGOBI® (futibatinib) Tablets for Previously Treated, Unresectable, Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Oakville , Ontario , Canada , United States , New Jersey , Switzerland , Horsham , Saskatchewan , Massachusetts , Canadian , American , Teruhiro Utsugi , Lipika Goyal , Judy Kay Moore , Gastroenterol Hepatol , Tim Whitten , Taiho Pharmaceutical Co Ltd , Hospital Cancer Center , Drug Administration , Janssen Pharmaceutical Companies , Taiho Oncology Inc , Prnewswire Taiho Oncology Inc , Otsuka Holdings Co Ltd , Incyte Corporation , American Cancer Society , Taiho Oncology , Massachusetts General Hospital Cancer Center , Taiho Pharmaceutical , Senior Managing Director , Pigment Epithelial Detachment , Corneal Keratitis , Soft Tissue Mineralization , Prescribing Information , Oncology Media Contact , Rev Gastroenterol ,